The ROE as of December 2025 (TTM) for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) is 15.79%

According to DaShenLin Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 15.79%. This represents a change of 304.96% compared to the average of 3.90% of the last 4 quarters.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Historical ROE (quarterly & annually)

How has 603233.SS ROE performed in the past?

The mean historical ROE of DaShenLin Pharmaceutical Group Co., Ltd. over the last ten years is 20.39%. The current 15.79% ROE has changed -22.55% with respect to the historical average. Over the past ten years (40 quarters), 603233.SS's ROE was at its highest in in the March 2016 quarter at 11.23%. The ROE was at its lowest in in the December 2021 quarter at -0.49%.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) ROE by Quarter and Year

Discovering the peaks and valleys of DaShenLin Pharmaceutical Group Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Average ROE

How has 603233.SS ROE performed in the past?

The current ROE of DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) ROE vs. Peers

How is 603233.SS’s ROE compared to its peers?

DaShenLin Pharmaceutical Group Co., Ltd.’s ROE is less than Anhui Anke Biotechnology (Group) Co., Ltd. (16.36%), less than Yunnan Botanee Bio-Technology Group Co.LTD (5.94%), less than Inner Mongolia Furui Medical Science Co., Ltd. (6.79%), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (-85.64%), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (-17.49%), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (14.47%), less than Autobio Diagnostics Co., Ltd. (12.66%), less than Liaoning Cheng Da Co., Ltd. (2.92%), less than Joincare Pharmaceutical Group Industry Co.,Ltd. (9.31%), less than China National Medicines Corporation Ltd. (11.45%),

Build a custom stock screener for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DaShenLin Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DaShenLin Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.